mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis E Screening in patients with immune impairment and increased transaminases levels) Mar Riveiro-Barciela; Luisa Roade; Joan Martínez-Camprecios; Judit Vidal-González; Basilio Rodríguez-Diez; Manel Perelló; Guillermo Ortí; Virginia Robles-Alonso; Cristina Berastegui; Jordi Navarro; Fernando Martínez-Valle; Itxarone Bilbao; Lluis Castells; Meritxell Ventura-Cots; Jordi Llaneras; Ariadna Rando-Segura; Xavier Forns; Sabela Lens; Martín Prieto; María García-Eliz; Arkaitz Imaz; Francisco Rodríguez-Frías; Maria Buti; Rafael Esteban;

Documento de posicionamiento de la «Societat Catalana de Digestologia» sobre elastografía hepática 2022 José Antonio Carrión; Isabel Graupera; Mercedes Vergara; Rosa Maria Morillas; Juan Manuel Pericàs; Maria Poca; Alberto Amador; Rosa Fernández; Teresa Monllor; Laura Muñoz; Concepció Bartres; Joan Genescà; Pere Ginés; Xavier Forns;

Evaluation of the clinical and economic value of sofosbuvir/velpatasvir (SOF/VEL) in patients with chronic hepatitis C in Spain during the last 5 years Rafael Esteban; Raquel Domínguez-Hernández; Helena Cantero; Miguel Ángel Casado;